GORMAN KEVIN CHARLES bought NBIX
May 27, 2026 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 5,248 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,248
Price
$0.00
Total value
N/A
InsiderGORMAN KEVIN CHARLES
Role—
SecurityNon-Qualified Stock Option
Transaction codeA: Grant or award
Transaction dateMay 27, 2026
Filing dateMay 29, 2026
Shares owned after5,248
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option vests in 12 monthly installments beginning June 27, 2026.